P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the ...

Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced positive topline results from two ...

Tamilnadu Dr M.G.R. Medical University (TNMGRMU) has recently released the results for various courses like BSc Nursing, MSc ...

Anna Podolanczuk, M.D., M.S., discusses how biomarker testing plays a role in diagnosing idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), helping to distinguish these ...